Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up
to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip